Concentrix Corp CNXC · NASDAQ
$28.22 +1.26% (+$0.35)
Summary
43 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $188.7M in the last fiscal year, 11% of its market value.
What to watch
- The company made a loss over the last 12 months.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 16% a year over 5 years. Over the last 3 years it grew by 16% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $2.39B.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 5.17%
- Raised in a row
- 4 years
You receive $1.44 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $33.5 is 19% above today's price. 78% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reportable Segment 100%
By region
- OTHERS 53%
- PHILIPPINES 17%
- UNITED STATES 12%
- INDIA 11%
- GERMANY 3.5%
- Other 3.2%
Reportable Segment brings in 100% of revenue.
Segments in detail